A 5-year follow-up of photocoagulation in diabetic macular edema: The prognostic value of vascular leakage for visual loss

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 11, 2008, Pages 1535-1539

  Sander, Birgit ^a,b   Hamann, Per ^a   Larsen, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood retinal barrier; Diabetic retinopathy; Leakage; Macular edema; Permeability; Photocoagulation

Indexed keywords

TRIAMCINOLONE; VASCULOTROPIN INHIBITOR;

ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FLUOROMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; LASER COAGULATION; LONG TERM CARE; MICROANEURYSM; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETINOPATHY; VASCULAR LEAKAGE; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FLUORESCEIN; FLUORESCENT DYES; FLUOROMETRY; FOLLOW-UP STUDIES; HUMANS; LIGHT COAGULATION; MACULAR EDEMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETINAL VESSELS; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY; VITREOUS BODY;

EID: 54049092383     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0892-6     Document Type: Article

References (21)

1. Early treatment diabetic retinopathy study research group (1991) Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report no.11. Ophthalmology 98:807-822
2. Early treatment diabetic retinopathy study research group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS report no.19. Arch Ophthalmol 113:1144-1155
3. Early treatment diabetic retinopathy study research group (1985) Photocoagulation for diabetic macular edema. ETDRS report no.1. Arch Ophthalmol 103:1796-1806
4. Early treatment diabetic retinopathy study research group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786-806
5. Strom C, Sander B, Larsen N, Larsen M, Lund-Andersen H (2002) Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci 43:241-245
6. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS, Larsen M (2008) Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol 86:364-371
7. Chew E, Strauber S, Beck R, Aiello LP, Antoszyk A, Bressler N, Browning D, Danis R, Fan J, Flaxel C, Friedman S, Glassman A, Kollman C, Lazarus H, Diabetic Retinopathy Clinical Researh Network (2007) Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: A pilot study. Ophthalmology 114:1190-1196
8. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K (2008) Comparative theraphy evaluation of intravitreal bevacizumab and trimacinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 145:854-861
9. Vinten M, Larsen M, Lund-Andersen H, Sander B, la Cour M (2007) Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta Ophthalmol 85:21-26
10. Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P (2006) Intravitreal trimacinolone acetonide for diffuse diabetic macular edema: Phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 142:794-799
11. Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M (2008) The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol 86:284-291
12. Sander B, Larsen M, Moldow B, Lund-Andersen H (2001) Diabetic macular edema: Passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42:433-438
13. Sander B, Thornit DN, Colmorn L, Strom C, Girach A, Hubbard LD, Lund-Andersen H, Larsen M (2007) Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Invest Ophthalmol Vis Sci 48:3983-3987
14. Moldow B, Sander B, Larsen M, Lund-Andersen H (1999) Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 40:1770-1775
15. Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N, Lund-Andersen H (2002) Diabetic macular oedema: A comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol 86:316-320
16. Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH (1994) Early changes in diabetic retinopathy: Capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol 72:553-559
17. Klein R, Klein B, Moss S, Davis M, DeMets D (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV Diabetic retinopathy. Ophthalmology 91:1464-1474
18. Cunha-Vaz J (1983) Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes. Diabetes 32:20-27
19. Castillo A, Benitez del Castillo JM, Diaz D, Sayagues O, Ruibal JL, Garcia-Sanchez J (1996) Analysis of the blood-retinal barrier: Its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetes. A 4-year follow-up. Graefes Arch Clin Exp Ophthalmol 234:246-250
20. Sander B, Larsen M, Engler C, Strøm C, Moldow B, Lund-Andersen H (2002) Diabetic macular oedema: The effect of photocoagulation on fluorescein transport across the blood-retinal barrier. Br J Ophthalmol 86:1139-1142
21. Klein R, Klein BE, Moss S, Cruickshanks KJ (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type diabetes. Ophthalmology 105:1801-1815